Katja Hardt

794 total citations
18 papers, 623 citations indexed

About

Katja Hardt is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Katja Hardt has authored 18 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Immunology and Allergy. Recurrent topics in Katja Hardt's work include Cell Adhesion Molecules Research (5 papers), Immune Response and Inflammation (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Katja Hardt is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Immune Response and Inflammation (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Katja Hardt collaborates with scholars based in Germany, Switzerland and Netherlands. Katja Hardt's co-authors include Wolf‐­Henning Boehncke, Sandra Diehl, Sandra Boehncke, R. Salgo, Ralf J. Ludwig, Roland Kaufmann, Claudia Buerger, Diamant Thaçi, Jūratė Garbaravičienė and Stephan Fichtlscherer and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Pain.

In The Last Decade

Katja Hardt

17 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Hardt Germany 13 358 188 136 95 91 18 623
Maria A. Beamer United States 8 280 0.8× 128 0.7× 117 0.9× 133 1.4× 92 1.0× 9 601
Laura Mercurio Italy 13 309 0.9× 180 1.0× 163 1.2× 109 1.1× 59 0.6× 22 561
Pei Qiao China 13 369 1.0× 229 1.2× 155 1.1× 69 0.7× 120 1.3× 30 685
Doina Diaconu United States 12 616 1.7× 135 0.7× 395 2.9× 118 1.2× 93 1.0× 15 846
Stefan Frischbutter Germany 15 474 1.3× 140 0.7× 144 1.1× 73 0.8× 455 5.0× 33 916
Ann E. Kelly-Welch United States 9 383 1.1× 185 1.0× 46 0.3× 104 1.1× 36 0.4× 10 672
Aya Kakizaki Japan 16 289 0.8× 149 0.8× 161 1.2× 245 2.6× 120 1.3× 42 694
Yves T. Falanga United States 11 315 0.9× 247 1.3× 48 0.4× 45 0.5× 73 0.8× 15 570
Chie Miyabe Japan 16 309 0.9× 277 1.5× 22 0.2× 137 1.4× 227 2.5× 34 882
Chun Guo China 17 558 1.6× 334 1.8× 22 0.2× 164 1.7× 57 0.6× 24 909

Countries citing papers authored by Katja Hardt

Since Specialization
Citations

This map shows the geographic impact of Katja Hardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Hardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Hardt more than expected).

Fields of papers citing papers by Katja Hardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Hardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Hardt. The network helps show where Katja Hardt may publish in the future.

Co-authorship network of co-authors of Katja Hardt

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Hardt. A scholar is included among the top collaborators of Katja Hardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Hardt. Katja Hardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liehr, Thomas, Anja Weise, Eva Miriam Buhl, et al.. (2025). Decoding HuH-7: a comprehensive genetic and molecular portrait of a widely used hepatocellular carcinoma model. Frontiers in Cell and Developmental Biology. 13. 1648639–1648639.
2.
Liehr, Thomas, Katja Hardt, Eva Miriam Buhl, et al.. (2025). Genetic and Molecular Characterization of H9c2 Rat Myoblast Cell Line. Cells. 14(7). 502–502. 7 indexed citations
3.
Buerger, Claudia, et al.. (2013). Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin. British Journal of Dermatology. 169(1). 156–159. 64 indexed citations
4.
Buerger, Claudia, Beatrice Richter, R. Salgo, et al.. (2012). Interleukin-1β Interferes with Epidermal Homeostasis through Induction of Insulin Resistance: Implications for Psoriasis Pathogenesis. Journal of Investigative Dermatology. 132(9). 2206–2214. 83 indexed citations
5.
Doberstein, Kai, Peter Baumgarten, Anja Wieland, et al.. (2011). PAX2 Regulates ADAM10 Expression and Mediates Anchorage-Independent Cell Growth of Melanoma Cells. PLoS ONE. 6(8). e22312–e22312. 22 indexed citations
6.
Boehncke, Sandra, R. Salgo, Jūratė Garbaravičienė, et al.. (2011). Effective continuous systemic therapy of severe plaque‐type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study. Journal of the European Academy of Dermatology and Venereology. 25(10). 1187–1193. 96 indexed citations
7.
Ludwig, Ralf J., Jūratė Garbaravičienė, Esther von Stebut, et al.. (2010). Platelet, Not Endothelial, P-Selectin Expression Contributes to Generation of Immunity in Cutaneous Contact Hypersensitivity. American Journal Of Pathology. 176(3). 1339–1345. 12 indexed citations
8.
Boehncke, Sandra, Stephan Fichtlscherer, R. Salgo, et al.. (2010). Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial. Archives of Dermatological Research. 303(6). 381–388. 54 indexed citations
9.
Boehncke, Sandra, Katja Hardt, Dirk Schadendorf, et al.. (2010). Endogenous μ-opioid peptides modulate immune response towards malignant melanoma. Experimental Dermatology. 20(1). 24–28. 34 indexed citations
10.
Doberstein, Kai, Claudia Bürger, Katja Hardt, et al.. (2010). ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma. Biochemical and Biophysical Research Communications. 401(3). 363–369. 12 indexed citations
11.
Schindewolf, Marc, Manfred Wolter, Katja Hardt, et al.. (2010). Diagnosis of heparin-induced delayed type hypersensitivity. Phlebologie. 39(4). 226–231. 9 indexed citations
12.
Ludwig, Ralf J., Katja Hardt, Roxana Bistrian, et al.. (2009). Junctional adhesion molecule (JAM)‐B supports lymphocyte rolling and adhesion through interaction with α4β1 integrin. Immunology. 128(2). 196–205. 36 indexed citations
13.
Ludwig, Ralf J., Katja Hardt, Jutta Will, et al.. (2009). Computer‐aided analysis of cell interactions under dynamic flow conditions. Experimental Dermatology. 18(3). 238–245. 4 indexed citations
14.
Schmidtko, Achim, Maria Burian, Katja Hardt, et al.. (2007). Pharmacological and histopathological characterization of a hyperalgesia model induced by freeze lesion. Pain. 127(3). 287–295. 7 indexed citations
15.
Rubant, Simone, Ralf J. Ludwig, Sandra Diehl, et al.. (2007). Dimethylfumarate Reduces Leukocyte Rolling in Vivo through Modulation of Adhesion Molecule Expression. Journal of Investigative Dermatology. 128(2). 326–331. 61 indexed citations
16.
Ludwig, Ralf J., Andreas Böck, Diamant Thaçi, et al.. (2006). Oligonucleotides Suppress IL-8 in Skin Keratinocytes In Vitro and Offer Anti-Inflammatory Properties In Vivo. Journal of Investigative Dermatology. 127(4). 846–854. 23 indexed citations
17.
Ludwig, Ralf J., Thomas M. Zollner, Sentot Santoso, et al.. (2005). Junctional Adhesion Molecules (JAM)-B and -C Contribute to Leukocyte Extravasation to the Skin and Mediate Cutaneous Inflammation. Journal of Investigative Dermatology. 125(5). 969–976. 79 indexed citations
18.
Ludwig, Ralf J., Manfred Wolter, Thomas M. Zollner, et al.. (2005). Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 3(7). 530–531. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026